Key result
Pharmacologic therapy during pregnancy requires balancing maternal treatment efficacy against potential fetal safety risks.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Supports individualized dosing adjustments during pregnancy; leaves open definitive fetal safety profiles for many medications.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Hansen et al. (2002) studied this question. Pharmacologic therapy for medical disorders during pregnancy requires balancing maternal treatment efficacy with potential fetal safety risks.
Synapse has enriched 10 related papers. Consider them for comparative context: